Palforzia Level 2 Capsules
Overview
What is this medicine?
How to Use This Medicine
When preparing your dose, do not swallow the capsules or inhale the powder. Instead, open the capsule or sachet and mix the contents with a small amount of soft food, such as applesauce, yogurt, or pudding. Mix well to ensure the medication is evenly distributed, but do not mix with liquids. Take your dose immediately after mixing, and do not store any leftover mixture for future use.
Continue taking this medication as directed by your doctor or healthcare provider, even if you start to feel better. After administering your dose, discard any remaining medication and wash your hands thoroughly.
If you have a scheduled appointment with your doctor to adjust your dosage, do not take your dose on that day.
To store this medication, keep it in the refrigerator or at room temperature. If you miss a dose, contact your doctor for guidance on what to do next.
Lifestyle & Tips
- Always carry two epinephrine auto-injectors and be prepared to use them.
- Continue to strictly avoid peanuts in your diet.
- Administer Palforzia daily, at approximately the same time each day, with food.
- Do not administer Palforzia if you are experiencing an asthma exacerbation, a viral illness, or other acute illness.
- Avoid strenuous exercise for at least 3 hours after taking Palforzia.
- Avoid hot showers or baths immediately after taking Palforzia.
- Report any allergic reactions or new symptoms to your healthcare provider immediately.
- Enroll in the PALFORZIA REMS program and understand its requirements.
Available Forms & Alternatives
Available Strengths:
- Palforzia Level 4 Capsules
- Palforzia Level 3 Capsules
- Palforzia Level 5 Capsules
- Palforzia Level 6 Capsules
- Palforzia 4-17yr Escalation Dose Pk
- Palforzia Level 1 Capsules
- Palforzia Level 8 Capsules
- Palforzia Level 9 Capsules
- Palforzia Level 2 Capsules
- Palforzia Level 11 (titration) Pow
- Palforzia Level 11 (maintenance)pow
- Palforzia Level 10 Capsules
- Palforzia Level 7 Capsules
Dosing & Administration
Adult Dosing
Condition-Specific Dosing:
Pediatric Dosing
Dose Adjustments
Renal Impairment:
Hepatic Impairment:
Pharmacology
Mechanism of Action
Pharmacokinetics
Absorption:
Distribution:
Elimination:
Pharmacodynamics
Safety & Warnings
BLACK BOX WARNING
Side Effects
Although rare, this medication can cause severe and potentially life-threatening side effects. If you experience any of the following symptoms, contact your doctor or seek medical attention immediately:
Signs of an allergic reaction, such as:
+ Rash
+ Hives
+ Itching
+ Red, swollen, blistered, or peeling skin with or without fever
+ Wheezing
+ Tightness in the chest or throat
+ Trouble breathing, swallowing, or talking
+ Unusual hoarseness
+ Swelling of the mouth, face, lips, tongue, or throat
Trouble swallowing or speaking
Pain when swallowing
Heartburn
Chest pain or pressure
Fast heartbeat
Passing out
Dizziness
Flushing
Shortness of breath
Severe diarrhea
Stomach cramps
In children, watch for:
Unusual crying
Feeling sluggish or extremely sleepy
Pulling legs up to the stomach
Other Possible Side Effects
Like all medications, this drug can cause side effects. While many people may not experience any side effects or only have mild ones, it's essential to discuss any concerns with your doctor. If you experience any of the following side effects or any other unusual symptoms that bother you or do not go away, contact your doctor:
Diarrhea
Stomach pain
Upset stomach
Vomiting
Itching in the ear, mouth, or tongue
Numbness or tingling in the mouth
Throat irritation
Cough
Runny or stuffy nose
* Sneezing
This list is not exhaustive, and you may experience other side effects. If you have questions or concerns, contact your doctor. You can also report side effects to the FDA at 1-800-332-1088 or online at https://www.fda.gov/medwatch.
Seek Immediate Medical Attention If You Experience:
- Difficulty breathing, wheezing, shortness of breath
- Throat tightness, hoarseness
- Hives, itching, flushing, swelling of face/lips/tongue
- Dizziness, lightheadedness, fainting
- Severe abdominal pain, vomiting, diarrhea
- Any signs of a severe allergic reaction
Before Using This Medicine
It is essential to inform your doctor about the following conditions to ensure safe treatment:
Any allergies you have, including allergies to this medication, its components, or other substances, such as foods or drugs. Be sure to describe the allergic reaction and its symptoms.
A history of life-threatening reactions to peanuts.
Previous severe allergic reactions.
Eosinophilic esophagitis or other eosinophilic diseases affecting the stomach or bowel.
* Heart problems, lung conditions, or mast cell disorders.
This list is not exhaustive, and it is crucial to discuss all your medications (prescription, over-the-counter, natural products, and vitamins) and health issues with your doctor and pharmacist. They will help determine if it is safe to take this medication with your other treatments and health conditions. Never start, stop, or adjust the dosage of any medication without consulting your doctor first.
Precautions & Cautions
If you consume alcohol, are experiencing an illness such as a viral infection, are fasting, are extremely tired or have missed sleep, are having your menstrual period, or are taking a nonsteroidal anti-inflammatory drug (NSAID) like ibuprofen or naproxen, discuss this with your doctor, as these factors may increase the risk of an allergic reaction.
Avoid taking this medication within 3 hours before or after exercising or taking a hot shower or bath. If you have recently exercised or taken a hot shower or bath and are experiencing symptoms such as feeling hot, sweating, or rapid breathing or heartbeat, wait until these symptoms subside before taking the medication.
If you have asthma and notice difficulty breathing or a worsening of your asthma symptoms, contact your doctor immediately. Additionally, if you are pregnant, planning to become pregnant, or are breast-feeding, consult your doctor to discuss the potential benefits and risks of this medication to both you and your baby.
Overdose Information
Overdose Symptoms:
- Severe allergic reaction (anaphylaxis)
- Worsening of existing allergic symptoms
What to Do:
Seek immediate medical attention. Administer epinephrine if signs of anaphylaxis are present. Call 911 or your local emergency number. Call 1-800-222-1222 (Poison Control).
Drug Interactions
Monitoring
Baseline Monitoring
Rationale: Confirm eligibility for treatment.
Timing: Prior to initiation
Rationale: To confirm diagnosis and establish baseline sensitivity.
Timing: Prior to initiation
Rationale: Uncontrolled asthma is a contraindication. Ensure asthma is well-controlled.
Timing: Prior to initiation and periodically
Rationale: EoE is a contraindication. Screen for symptoms.
Timing: Prior to initiation
Routine Monitoring
Frequency: During and after each dose of Initial Dose Escalation and the first dose of each Up-Dosing level.
Target: Absence of severe reactions.
Action Threshold: Any signs of allergic reaction, especially severe symptoms, require immediate intervention (e.g., epinephrine).
Frequency: Regularly throughout treatment.
Target: Well-controlled asthma.
Action Threshold: Worsening asthma symptoms may require temporary interruption or discontinuation of Palforzia.
Frequency: Regularly throughout treatment.
Target: Absence of symptoms (e.g., dysphagia, vomiting, abdominal pain).
Action Threshold: New or worsening symptoms of EoE require evaluation and potential discontinuation.
Symptom Monitoring
- Hives
- Swelling (face, lips, tongue, throat)
- Difficulty breathing (wheezing, shortness of breath)
- Cough
- Throat tightness
- Dizziness
- Lightheadedness
- Fainting
- Abdominal pain
- Vomiting
- Diarrhea
- Flushing
- Itching
- Runny nose
- Sneezing
- Watery eyes
Special Patient Groups
Pregnancy
There are no adequate and well-controlled studies of Palforzia in pregnant women. Use only if the potential benefit justifies the potential risk to the fetus. Consider the risk of anaphylaxis in the mother and fetus.
Trimester-Specific Risks:
Lactation
It is not known whether peanut allergen powder is excreted in human milk. The developmental and health benefits of breastfeeding should be considered along with the motherβs clinical need for Palforzia and any potential adverse effects on the breastfed infant from Palforzia or from the underlying maternal condition. Consider the risk of anaphylaxis in the mother.
Pediatric Use
Approved for ages 4 to 17 years. Safety and effectiveness in children younger than 4 years have not been established. Dosing is the same as for adults.
Geriatric Use
Clinical studies of Palforzia did not include sufficient numbers of subjects aged 65 and over to determine whether they respond differently from younger subjects. In general, dose selection for an elderly patient should be cautious, reflecting the greater frequency of decreased hepatic, renal, or cardiac function, and of concomitant disease or other drug therapy.
Clinical Information
Clinical Pearls
- Palforzia is NOT a cure for peanut allergy; patients must continue strict peanut avoidance.
- Epinephrine auto-injectors must be readily available and patients/caregivers trained on their use.
- Initial Dose Escalation and the first dose of each Up-Dosing level MUST be administered in a healthcare setting with anaphylaxis management capabilities.
- Patients should not take Palforzia if they are sick (e.g., viral illness, asthma exacerbation) as this increases the risk of adverse reactions.
- Contraindicated in patients with uncontrolled asthma or eosinophilic esophagitis.
- Adherence to the daily dosing regimen is critical for maintaining desensitization.
- Counsel patients on the importance of avoiding factors that can increase the risk of allergic reactions (e.g., exercise, hot showers, alcohol consumption) around the time of dosing.
Alternative Therapies
- Strict peanut avoidance (standard of care prior to Palforzia)
- Omalizumab (Xolair) - may be used as an adjunct to oral immunotherapy to reduce reactions, but not approved as monotherapy for desensitization.
- Other investigational oral immunotherapies or epicutaneous patch therapies (not yet FDA approved for general use).